Cardiovascular Therapeutics (Jan 2024)

Cysteine Leukotriene Receptor Antagonist—Montelukast—Treatment Improves Experimental Abdominal Aortic Aneurysms in Mice

  • Kexin Li,
  • Meng Li,
  • Panpan Wei,
  • Kangli Tian,
  • Haole Liu,
  • Weilai Fu,
  • Haiwen Hou,
  • Yajie Chen,
  • Baohui Xu,
  • Yankui Li,
  • Sihai Zhao

DOI
https://doi.org/10.1155/2024/8826287
Journal volume & issue
Vol. 2024

Abstract

Read online

Conclusion: Montelukast treatment improves experimental nondissected AAAs in mice partly by improving aortic inflammation.